CGEN
Price:
$1.61
Market Cap:
$150.59M
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients with advanced malignancies as a monotherapy; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with solid tumors; and AZD2936, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase I/II clinical ...[Read more]
Industry
Biotechnology
IPO Date
2000-08-11
Stock Exchange
NASDAQ
Ticker
CGEN
According to Compugen Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 147.09M. This represents a change of 4.06% compared to the average of 141.35M of the last 4 quarters.
The mean historical Enterprise Value of Compugen Ltd. over the last ten years is 261.38M. The current 147.09M Enterprise Value has changed 5.53% with respect to the historical average. Over the past ten years (40 quarters), CGEN's Enterprise Value was at its highest in in the September 2020 quarter at 1.22B. The Enterprise Value was at its lowest in in the September 2022 quarter at -29322609.55.
Average
261.38M
Median
180.28M
Minimum
52.81M
Maximum
959.87M
Discovering the peaks and valleys of Compugen Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 356.36%
Maximum Annual Enterprise Value = 959.87M
Minimum Annual Increase = -85.21%
Minimum Annual Enterprise Value = 52.81M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 121.66M | -25.24% |
| 2023 | 162.73M | 208.12% |
| 2022 | 52.81M | -85.21% |
| 2021 | 357.03M | -62.80% |
| 2020 | 959.87M | 183.17% |
| 2019 | 338.97M | 356.36% |
| 2018 | 74.28M | -31.06% |
| 2017 | 107.75M | -45.54% |
| 2016 | 197.84M | -17.87% |
| 2015 | 240.87M | -26.02% |
The current Enterprise Value of Compugen Ltd. (CGEN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
112.40M
5-year avg
330.82M
10-year avg
261.38M
Compugen Ltd.’s Enterprise Value is greater than Innate Pharma S.A. (127.63M), greater than Nuvectis Pharma, Inc. (145.94M), greater than Molecular Partners AG (46.65M), less than Milestone Pharmaceuticals Inc. (235.37M), greater than Rani Therapeutics Holdings, Inc. (123.77M), greater than Cybin Inc. (63.89M), greater than Tonix Pharmaceuticals Holding Corp. (46.35M), greater than Cardiff Oncology, Inc. (136.29M), greater than Cassava Sciences, Inc. (48.00M), greater than Corbus Pharmaceuticals Holdings, Inc. (116.42M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 127.63M | $160.90M | |
| 145.94M | $172.73M | |
| 46.65M | $168.84M | |
| 235.37M | $224.85M | |
| 123.77M | $114.60M | |
| 63.89M | $296.80M | |
| 46.35M | $171.19M | |
| 136.29M | $145.42M | |
| 48.00M | $160.38M | |
| 116.42M | $134.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Compugen Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Compugen Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Compugen Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Compugen Ltd. (CGEN)?
What is the 3-year average Enterprise Value for Compugen Ltd. (CGEN)?
What is the 5-year average Enterprise Value for Compugen Ltd. (CGEN)?
How does the current Enterprise Value for Compugen Ltd. (CGEN) compare to its historical average?